An alcohol-related liver disease (ALD) diagnosis acts as a powerful catalyst for reducing alcohol consumption, but a significant number of patients relapse quickly, according to new research.
The observational study tracked 104 patients newly diagnosed with ALD at a Danish hospital. Researchers found that shortly after diagnosis, the percentage reporting heavy alcohol use dropped dramatically from 76% to 24%. However, biomarker testing revealed that true abstinence rates were lower than patient self-reports suggested.
A key finding was the relapse rate. Among those initially abstinent, 37% returned to drinking within just 90 days. The study identified motivation and confidence as critical factors for sustained abstinence, not the severity of the liver disease itself.
These results highlight a crucial window for clinical intervention immediately following an ALD diagnosis. Researchers argue for integrating structured alcohol treatment directly into liver care to address the high risk of early relapse and support long-term health.